Bcl 2 (Control Peptide) (B Cell Leukemia 2)

• Catalog number
  MBS659532
• Price
  Please ask
• Size
  5x0.05 mg

• Products_type
  Peptide
• Products_short_name
  [Bcl 2]
• Other_names
  [BCL-2, partial; Apoptosis regulator Bcl-2; apoptosis regulator Bcl-2; Bcl2-like protein; B-cell leukemia/lymphoma 2; B cell lymphoma 2 associated oncogene; B-cell CLL/lymphoma 2]
• Other_gene_names
  [Bcl2; Bcl2; Bcl-2; Bcl-2]
• Purity
  PurifiedPurified
• Form
  Supplied as a liquid in PBS, pH 7.2, 0.1% BSA, 0.02% sodium azide.
• Storage_stability
  May be stored at 4 degree C for short-term only. For long-term storage, store at -20 degree C. Aliquots are stable for at least 6 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
• Tested_application
  ELISA (EL/EIA), Western Blot (WB)
• Description
  For cells, cell lines and tissues in culture till half confluency. Isotype or positive controls by peptides, antibodies and deactivated samples. Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

• Gene target
  Bcl   Peptide   Leukemia  
• Short name
  Bcl 2 (Control Peptide) (B Leukemia 2)
• Technique
  Control, peptide, controls, peptides
• Alternative name
  Bcl 2 (reference short protein sequence) (B cellular Leukemia 2)
• Alternative technique
  peptides, controls
• Tissue
  cell, control
• Virus
  leukemia

MeSH Data

• Name
  Leukemia, Experimental
• Concept
  Scope note: Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.
• Tree numbers
  • C04.557.337.372
  • C04.619.531
  • E05.598.500.496.500
• Qualifiers
  diagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, rehabilitation, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, psychology, urine, virology, history, classification, economics, embryology, genetics, nursing, radiotherapy, ethnology, prevention & control, pathology, metabolism, complications, surgery

Similar products